Karagiannis Dimitrios A, Lygerou Meropi, Papadopoulos Georgios, Kabanarou Stamatina A, Aspiotis Miltiadis, Dardabounis Doukas C, Minakakis Panagiotis G, Spai Sofia I, Koutsandrea Chrysanthi, Oikonomidis Panagiotis, Pantelopoulou Georgia N, Kousidou Olga C, Tsilimbaris Miltiadis
Ophthalmiatrio Athens Hospital, Athens 10672, Greece.
OMMA, Ophthalmological Institute of Athens, Athens 11525, Greece.
Clin Ophthalmol. 2020 May 25;14:1417-1426. doi: 10.2147/OPTH.S240417. eCollection 2020.
This multicenter, epidemiological, cross-sectional study aimed to estimate the annual cumulative incidence of major macular diseases that cause visual impairment and require therapeutic intervention in the routine care of Greece.
The study was carried out between December 2012 and May 2015 in 20 ophthalmology clinics. Over a one-year recruitment period per study site, all treatment naïve adult patients newly diagnosed with wet age-related macular degeneration, visual impairment due to diabetic macular edema or macular edema secondary to retinal vein occlusion requiring therapeutic management and who had not been diagnosed or treated for the same disease in the past were enrolled after providing informed consent. Study data were collected during the single study visit.
A total of 1532 incident cases were enrolled. The estimated annual cumulative incidence of wet age-related macular degeneration, diabetic macular edema and macular edema secondary to retinal vein occlusion requiring therapeutic management was 0.82 [95% confidence interval (CI): 0.76, 0.88; n=723], 0.63 (95% CI: 0.58, 0.69; n=559), and 0.29 (95% CI: 0.25, 0.32; n=250) per 10,000 cases, respectively.
The study provides estimates of the incidence of major macular diseases causing visual impairment and requiring treatment in outpatient hospital settings in Greece, indicating a considerable socioeconomic burden to the healthcare system.
本多中心、流行病学横断面研究旨在估计在希腊常规医疗中导致视力损害并需要进行治疗干预的主要黄斑疾病的年累积发病率。
该研究于2012年12月至2015年5月在20家眼科诊所开展。在每个研究地点为期一年的招募期内,所有初治的成年患者,若新诊断为湿性年龄相关性黄斑变性、因糖尿病性黄斑水肿或视网膜静脉阻塞继发黄斑水肿而导致视力损害且需要进行治疗管理,并且过去未曾被诊断或治疗过相同疾病,在获得知情同意后被纳入研究。研究数据在单次研究访视期间收集。
共纳入1532例新发病例。湿性年龄相关性黄斑变性、糖尿病性黄斑水肿以及需要治疗管理的视网膜静脉阻塞继发黄斑水肿的估计年累积发病率分别为每10000例0.82[95%置信区间(CI):0.76,0.88;n = 723]、0.63(95%CI:0.58,0.69;n = 559)和0.29(95%CI:0.25,0.32;n = 250)。
本研究提供了希腊门诊医院环境中导致视力损害并需要治疗的主要黄斑疾病的发病率估计值,表明对医疗保健系统存在相当大的社会经济负担。